Scientists comment on NICE final draft guidance and the NHS rollout of Alyftrek for Cystic Fibrosis.   Prof David Sheppard, … read more

Cystic Fibrosis (CF) is an incurable, life-limiting condition, affecting over 11,300 people in the UK costing the NHS millions in … read more

Scientists react to final NICE Guidance on the Cystic Fibrosis drug Kaftrio.    David Ramsden, Chief Executive of Cystic Fibrosis … read more

Scientists react to MHRA licensing cystic fibrosis medication for younger children.    Kevin Southern, Professor of Child Health, Chair, UK … read more

NHS England have announced that UK patients will be able to access a new treatment for Cystic Fibrosis, combing the … read more